Whalegun
Home

Amylyx Pharmaceuticals AMLX paid Tarplin, Downs & Young $40K for lobbying in Q3 2024 · Health Issues, Medicare

Trade details

Type
Lobbying report
Amount
$40,000
Quarter
Q3 2024
Stock
Amylyx Pharmaceuticals AMLX
Client
Amylyx Pharmaceuticals
Reported
24/10/18

Down 50.0% from last quarter

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/08/31~24/10/30

Amylyx Pharmaceuticals's other lobbying reports

  • Amylyx Pharmaceuticals

    LobbyingAmylyx Pharmaceuticals

    $40K

    Reported 07/16

  • Amylyx Pharmaceuticals

    LobbyingAmylyx Pharmaceuticals

    $40K

    Reported 04/20

  • Amylyx Pharmaceuticals

    LobbyingAmylyx Pharmaceuticals

    $40K

    Reported 01/20

  • Amylyx Pharmaceuticals

    LobbyingAmylyx Pharmaceuticals

    $40K

    Reported 25/10/16

  • Amylyx Pharmaceuticals

    LobbyingAmylyx Pharmaceuticals

    $40K

    Reported 25/07/16